New research from the Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) has confirmed the accuracy of modern radiotherapy techniques for cancer treatment. The study focuses on optimizing treatment to reduce harm to healthy tissues while enhancing efficacy. Dr. Andrew Alves highlighted that advancements in technology allow for higher dose, hypofractionated radiotherapy, which requires fewer treatment sessions and more precise targeting of the radiation beam. This method has a narrow margin for error, prompting the development of a customized audit to validate patient doses. The study, which examined over 700 treatments, is intended to serve as a benchmark for clinics in Australia and worldwide, reinforcing the importance of accurate radiotherapy in improving patient outcomes.
Wed, 20 Aug 2025 23:12:00 GMT | Scimex